261 related articles for article (PubMed ID: 24704970)
1. Immunopathogenesis of HTLV-1-assoaciated myelopathy/tropical spastic paraparesis (HAM/TSP).
Fuzii HT; da Silva Dias GA; de Barros RJ; Falcão LF; Quaresma JA
Life Sci; 2014 May; 104(1-2):9-14. PubMed ID: 24704970
[TBL] [Abstract][Full Text] [Related]
2. Proviral load and immune markers associated with human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Peru.
Best I; Adaui V; Verdonck K; González E; Tipismana M; Clark D; Gotuzzo E; Vanham G
Clin Exp Immunol; 2006 Nov; 146(2):226-33. PubMed ID: 17034574
[TBL] [Abstract][Full Text] [Related]
3. Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers.
Santos SB; Porto AF; Muniz AL; de Jesus AR; Magalhães E; Melo A; Dutra WO; Gollob KJ; Carvalho EM
BMC Infect Dis; 2004 Mar; 4():7. PubMed ID: 15070424
[TBL] [Abstract][Full Text] [Related]
4. Human T-lymphotropic virus type 1 (HTLV-1) and regulatory T cells in HTLV-1-associated neuroinflammatory disease.
Araya N; Sato T; Yagishita N; Ando H; Utsunomiya A; Jacobson S; Yamano Y
Viruses; 2011 Sep; 3(9):1532-48. PubMed ID: 21994794
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Rafatpanah H; Farid Hosseini R; Pourseyed SH
Iran J Basic Med Sci; 2013 Mar; 16(3):235-41. PubMed ID: 24470869
[TBL] [Abstract][Full Text] [Related]
6. HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations.
Saab L; DiCapua D; Zubair AS
J Neurol Sci; 2024 Apr; 459():122973. PubMed ID: 38520941
[TBL] [Abstract][Full Text] [Related]
7. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease.
Yamano Y; Takenouchi N; Li HC; Tomaru U; Yao K; Grant CW; Maric DA; Jacobson S
J Clin Invest; 2005 May; 115(5):1361-8. PubMed ID: 15864353
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report.
Sanz M; Chernet S; Shymansky J; Mandel A; Chitrakar A; Kaminski HJ; Ghosh P; Soriano-Sarabia N
J Neuroimmunol; 2024 Mar; 388():578294. PubMed ID: 38306927
[TBL] [Abstract][Full Text] [Related]
9. High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease.
Goon PK; Igakura T; Hanon E; Mosley AJ; Asquith B; Gould KG; Taylor GP; Weber JN; Bangham CR
J Virol; 2003 Sep; 77(17):9716-22. PubMed ID: 12915584
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory cytokine gene induction by human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2 Tax in primary human glial cells.
Banerjee P; Rochford R; Antel J; Canute G; Wrzesinski S; Sieburg M; Feuer G
J Virol; 2007 Feb; 81(4):1690-700. PubMed ID: 17121800
[TBL] [Abstract][Full Text] [Related]
11. Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study.
Davoudi M; Boostani R; Manzari ZS
Iran J Med Sci; 2024 May; 49(5):294-301. PubMed ID: 38751877
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-10 Gene Polymorphisms and Human T Lymphotropic Virus Type I-Associated Myelopathy/tropical Spastic Paraparesis in North-East of Iran (Mashhad).
Shirdel A; Azarpazhooh MR; Sahebari M; Ghanbari M; Mirfeizi SZ; Hutchinson I; Ziaee A; Rafatpanah H
Iran J Basic Med Sci; 2013 Mar; 16(3):258-63. PubMed ID: 24470873
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell maturation, but not type I interferon exposure, restricts infection by HTLV-1, and viral transmission to T-cells.
Rizkallah G; Alais S; Futsch N; Tanaka Y; Journo C; Mahieux R; Dutartre H
PLoS Pathog; 2017 Apr; 13(4):e1006353. PubMed ID: 28426803
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of TGF-beta signaling and regulatory and effector T-cell function in virus-induced neuroinflammatory disease.
Grant C; Oh U; Yao K; Yamano Y; Jacobson S
Blood; 2008 Jun; 111(12):5601-9. PubMed ID: 18326816
[TBL] [Abstract][Full Text] [Related]
15. Non-cancerous complications in HTLV-1 carriers.
Ohmoto A; Fuji S
Expert Rev Anti Infect Ther; 2024 May; 22(5):307-316. PubMed ID: 38536666
[TBL] [Abstract][Full Text] [Related]
16. Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
Matos Cunha LC; Campelo Tavares M; Tierra Criollo CJ; Labanca L; Cardoso Dos Santos Couto Paz C; Resende Martins H; de Freitas Carneiro-Proietti AB; Utsch Goncalves D
J Clin Neurol; 2013 Oct; 9(4):252-8. PubMed ID: 24285967
[TBL] [Abstract][Full Text] [Related]
17. Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease.
Bittencourt AL; Farre L
Int J Infect Dis; 2024 Apr; 145():107058. PubMed ID: 38697604
[TBL] [Abstract][Full Text] [Related]
18. Establishing phenotypic features associated with morbidity in human T-cell lymphotropic virus type 1 infection.
Brito-Melo GE; Souza JG; Barbosa-Stancioli EF; Carneiro-Proietti AB; Catalan-Soares B; Ribas JG; Thorum GW; Rocha RD; Martins-Filho OA;
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1105-10. PubMed ID: 15539514
[TBL] [Abstract][Full Text] [Related]
19. Neurological aspects of HTLV-1 infection: symptoms in apparently asymptomatic carriers.
Ferreira QR; Novaes AF; Santana CS; Umeda AS; de Souza Nascimento JO; de Freitas Santos JPM; Fernandes LA; Moura MN; Amorim RL; Cavalcanti VN; da Cruz ALB; Barreto FK; Costa DT
J Neurovirol; 2024 Apr; ():. PubMed ID: 38653958
[TBL] [Abstract][Full Text] [Related]
20. Pregnancy complicated by HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP): a case report.
Mori H; Shibata E; Kuwazuru T; Uchimura T; Kondo E; Iwanaka Y; Yoshino K
Clin Case Rep; 2021 Jul; 9(7):e04511. PubMed ID: 34322258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
